These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 31455682)
1. Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma. Nguyen R; Moustaki A; Norrie JL; Brown S; Akers WJ; Shirinifard A; Dyer MA Clin Cancer Res; 2019 Dec; 25(24):7554-7564. PubMed ID: 31455682 [TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma. Nguyen R; Houston J; Chan WK; Finkelstein D; Dyer MA Cancer Immunol Immunother; 2018 Apr; 67(4):615-626. PubMed ID: 29327110 [TBL] [Abstract][Full Text] [Related]
3. Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma. Nguyen R; Zhang X; Sun M; Abbas S; Seibert C; Kelly MC; Shern JF; Thiele CJ Clin Cancer Res; 2022 Sep; 28(17):3785-3796. PubMed ID: 35802683 [TBL] [Abstract][Full Text] [Related]
5. Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance. Tibbetts R; Yeo KK; Muthugounder S; Lee MH; Jung C; Porras-Corredor T; Sheard MA; Asgharzadeh S Cancer Immunol Immunother; 2022 Jan; 71(1):153-164. PubMed ID: 34043024 [TBL] [Abstract][Full Text] [Related]
6. NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced Xu X; Huang W; Heczey A; Liu D; Guo L; Wood M; Jin J; Courtney AN; Liu B; Di Pierro EJ; Hicks J; Barragan GA; Ngai H; Chen Y; Savoldo B; Dotti G; Metelitsa LS Clin Cancer Res; 2019 Dec; 25(23):7126-7138. PubMed ID: 31484667 [TBL] [Abstract][Full Text] [Related]
7. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice. Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727 [TBL] [Abstract][Full Text] [Related]
8. Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating. Chen RL; Reynolds CP; Seeger RC Cancer Immunol Immunother; 2000 Feb; 48(11):603-12. PubMed ID: 10663607 [TBL] [Abstract][Full Text] [Related]
9. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity. Shibina A; Seidel D; Somanchi SS; Lee DA; Stermann A; Maurer BJ; Lode HN; Reynolds CP; Huebener N J Mol Med (Berl); 2013 Apr; 91(4):459-72. PubMed ID: 23052481 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival. Yang RK; Kalogriopoulos NA; Rakhmilevich AL; Ranheim EA; Seo S; Kim K; Alderson KL; Gan J; Reisfeld RA; Gillies SD; Hank JA; Sondel PM Cancer Immunol Immunother; 2013 Aug; 62(8):1303-13. PubMed ID: 23661160 [TBL] [Abstract][Full Text] [Related]
11. Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro. Hank JA; Surfus J; Gan J; Chew TL; Hong R; Tans K; Reisfeld R; Seeger RC; Reynolds CP; Bauer M J Immunother Emphasis Tumor Immunol; 1994 Jan; 15(1):29-37. PubMed ID: 8110728 [TBL] [Abstract][Full Text] [Related]
12. Combining Immunocytokine and Bates PD; Rakhmilevich AL; Cho MM; Bouchlaka MN; Rao SL; Hales JM; Orentas RJ; Fry TJ; Gilles SD; Sondel PM; Capitini CM Front Immunol; 2021; 12():668307. PubMed ID: 34489927 [TBL] [Abstract][Full Text] [Related]
14. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy. Liu Y; Wu HW; Sheard MA; Sposto R; Somanchi SS; Cooper LJ; Lee DA; Seeger RC Clin Cancer Res; 2013 Apr; 19(8):2132-43. PubMed ID: 23378384 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Fukuda M; Horibe K; Furukawa K Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237 [TBL] [Abstract][Full Text] [Related]
16. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro. Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368 [TBL] [Abstract][Full Text] [Related]